HAVIT Blog

Science-backed guides on habits, sleep, nutrition, and movement.

LatestBest Calorie Counter Apps in 2026 (Free and Paid): Every Major App, Reviewed One by OneEvery number in a calorie app is an estimate, so choose on consistency rather than claimed accuracy. Data provenance matters more than database size — and check what happens after the number.

All articles

GLP-1 for Perimenopause: Weight Gain & Insulin (2026)

GLP-1 for perimenopause is used to treat the weight gain, rising insulin resistance, and belly fat that begin during the transition years — often while you are still having periods — not perimenopause itself. Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) can help, but protein and strength training are essential because perimenopause is when lean-muscle loss accelerates.

GLP-1 Plotter: Chart Your Medication Level & Weight Over Time

A GLP-1 plotter charts your medication level between weekly doses, your weight-trend curve, and your dose timeline — so you can see the whole picture, not one number.

GLP-1 Postpartum: Breastfeeding Safety & Weight (2026)

GLP-1s are not recommended while breastfeeding. The US Wegovy (semaglutide) label advises against breastfeeding with Wegovy tablets and calls for a benefit–risk decision for the injection, the EU label says semaglutide should not be used while breastfeeding, and clinical guidance advises avoiding tirzepatide while nursing. GLP-1s must also be stopped in pregnancy. Any use for postpartum weight loss is an individual decision to make with your OB-GYN — usually only once you are no longer breastfeeding.

GLP-1 Progress Tracker: See Results Beyond the Scale

A GLP-1 progress tracker follows your weight trend, body composition, measurements, photos and non-scale victories — so you see real progress even when the scale stalls.

GLP-1 Shot Tracker: Log Every Weekly Injection & Site

A GLP-1 shot tracker logs each weekly injection — date, rotated site, and missed-dose window for Wegovy, Ozempic & tirzepatide. See exactly how to track a shot.

Lose It! Alternative for GLP-1 Users: An Honest 2026 Comparison — HAVIT vs Lose It

Looking for a Lose It! alternative on Ozempic or Zepbound? What Lose It! does well as a calorie counter, where it falls short for GLP-1, and what to look for.

MacroFactor Alternative for GLP-1 Users: An Honest 2026 Comparison — HAVIT vs MacroFactor

Looking for a MacroFactor alternative on a GLP-1? What MacroFactor's macro coaching does brilliantly, why it doesn't track your dose, and what to look for.

Oral Wegovy Side Effects: Nausea & Warnings (2026)

Oral Wegovy's most common side effects are gastrointestinal — nausea, diarrhea, vomiting, constipation, and abdominal pain — usually mild-to-moderate and worst during dose increases. Because oral Wegovy is the same molecule as injectable Wegovy (semaglutide), it shares the *same* side-effect profile and the *same* serious warnings, including pancreatitis, gallbladder disease, and a boxed thyroid warning.

Orforglipron Side Effects: Nausea, Warnings (2026)

Orforglipron's most common side effects are gastrointestinal — nausea, diarrhea, constipation, and vomiting — which are dose-dependent, tend to be worst around each dose increase, and usually settle as the body adapts. Rare but serious risks include a boxed warning for thyroid C-cell tumors plus pancreatitis and gallbladder disease, which need urgent medical care.

Phaze Alternative for GLP-1 Users: An Honest 2026 Comparison — HAVIT vs Phaze

Looking for a Phaze alternative on Ozempic or Zepbound? What Phaze does well, where it fits best, and how HAVIT compares as a whole-lifestyle alternative.

Pillyze Alternative for GLP-1 Users: An Honest 2026 Comparison — HAVIT vs Pillyze

Looking for a Pillyze alternative on a GLP-1? Pillyze is a strong diet, supplement, and glucose app — but it doesn't track your shot. How HAVIT compares.

GLP-1 First Month: What to Expect on Ozempic & Wegovy (2026)

In your first month on a GLP-1, you start at the lowest dose — semaglutide 0.25 mg (Ozempic/Wegovy injections) or tirzepatide 2.5 mg (Mounjaro/Zepbound) — for four weeks. Expect mild early nausea, a fading appetite, and small, gradual weight loss. The starter dose is for adjustment, not results.